Harvard Bioscience

HBIO

Capitalización de mercado USD 36.8 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	WCM 1 Weber Capital Management San Francisco, California	USD 1.91 M	-USD 55 k	-9,176	-3%
2	MIM 2 Meros Investment Management Dallas, Texas	USD 1.13 M	+USD 386 k	+64,470	+54%
3	3 Acadian Asset Management Boston, Massachusetts	USD 1.1 M	–	–	–
4	4 Vanguard Capital Management Malvern, Pennsylvania	USD 1.04 M	+USD 37.8 k	+6,312	+4%
5	NCNMGF 5 Nano-Cap New Millennium Growth Fund Staten Island, New York	USD 880 k	+USD 153 k	+25,582	+22%
6	6 Corsair Capital Management New York	USD 755 k	-USD 12 k	-2,000	-2%
7	7 Two Sigma Investments New York	USD 704 k	+USD 2.56 k	+428	+0.4%
8	8 Renaissance Technologies New York	USD 611 k	-USD 12.6 k	-2,100	-2%
9	9 BlackRock New York	USD 380 k	-USD 2.35 k	-392	-0.6%
10	10 Geode Capital Management Boston, Massachusetts	USD 293 k	-USD 71.6 k	-11,956	-20%
11	MBAM 11 Mink Brook Asset Management West Palm Beach, Florida	USD 205 k	+USD 200 k	+33,369	Nuevas
12	12 Millennium Management New York	USD 201 k	-USD 82.1 k	-13,712	-30%
13	13 Vanguard Fiduciary Trust Malvern, Pennsylvania	USD 171 k	–	–	–
14	14 Essex Investment Management Boston, Massachusetts	USD 166 k	-USD 288	-48	-0.2%
15	WN 15 Williams & Novak Westlake Village, California	USD 129 k	-USD 36.6 k	-6,103	-23%
16	16 UBS Group Zurich, Switzerland	USD 108 k	+USD 55 k	+9,176	+109%
17	17 RBF Capital San Francisco, California	USD 98.4 k	–	–	–
18	18 State Street Boston, Massachusetts	USD 91.8 k	–	–	–
19	19 Jane Street New York	USD 86 k	-USD 59 k	-9,848	-41%
20	20 Citadel Advisors Miami, Florida	USD 81.5 k	+USD 79.4 k	+13,251	Nuevas
21	21 Goldman Sachs New York	USD 65.5 k	+USD 63.8 k	+10,657	Nuevas
22	22 Bank of New York Mellon New York	USD 62.9 k	–	–	–
23	23 Fidelity Investments Boston, Massachusetts	USD 19.6 k	-USD 569	-95	-3%
24	24 Morgan Stanley New York	USD 10 k	-USD 6	-1	-0.1%
25	25 Vanguard Global Advisers Malvern, Pennsylvania	USD 7.51 k	–	–	–

Harvard Bioscience HBIO Capitalización de mercado USD 36.8 M

Harvard Bioscience

HBIO

Capitalización de mercado USD 36.8 M